A 2023 randomized controlled trial involving 208 participants found that mindfulness-based stress reduction (MBSR) is noninferior to escitalopram, a commonly used first-line psychopharmacologic treatment for anxiety disorders.

Authors

• Person: Not available Organization: National Center for Complementary and Integrative Health
  Mind and Body Approaches for Stress and Anxiety - nccih

Sources

• Mind and Body Approaches for Stress and Anxiety - nccih www.nccih.nih.gov National Center for Complementary and Integrative Health via serper
• Anxiety and Complementary Health Approaches | NCCIH - NIH www.nccih.nih.gov National Center for Complementary and Integrative Health via serper

Referenced by nodes (2)

• anxiety disorders concept
• Mindfulness-Based Stress Reduction concept